Viral-mediated Gene Transfer System
The inventors were the first to propose the use of viral DNA vectors as a general way to transfer genes into mammalian cells. They also were the first to directly administer a human gene in vivo and obtain expression in an experimental animal. Their viral-mediated gene transfer system is now the basic technique that many companies have adopted over the past decade.
Inventors
- William N. Kelley, University of Michigan
- Thomas Palella, University of Michigan
- Myron Levine, University of Michigan
US Patent
5,672,344
- bgh Polyadenylation Signal
- Blue Noise Mask
- Cisplatin and Carboplatin Anticancer Drugs
- Deimmunized Sarcin Ribotoxin
- Endotoxin-free ClearColi™ Expression System
- Fibronectin Artificial Antibody Scaffold
- Fullerenes
- Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
- mRNA Transport Enhancer
- PEGylation: Non-Immunogenic Delivery of Protein-Based Drugs
- Pichia Classic Expression Platform
- Pichia GlycoSwitch® Protein Expression System
- Pichia Protein Expression System
- Prostate-Specific Antigen Blood Test for Prostate Cancer
- Shingles Vaccine Antigen
- Silver Sulfadiazine Burn Ointment
- Technetium-99M Complexes for Cardiac Imaging
- The CH2 Domain Scaffold – ABDURINS™
- Ultrasound Tissue Harmonic Imaging
- VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
- Viral-mediated Gene Transfer System